Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients

SL Groenland, Ruben van Eerden, R B Verheijen, N Vries, B Thijssen, H Rosing, JH Beijnen, Stijn Koolen, Ron Mathijssen, ADR Huitema, N Steeghs

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)941-948
Number of pages8
JournalClinical Pharmacokinetics
Volume59
Issue number7
DOIs
Publication statusPublished - 2020

Cite this